v3.26.1
Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Research and development expenses $ 3,731 $ 7,620 $ 17,034
General and administrative expenses 3,245 3,183 5,237
Impairment loss 20,482 202
Operating loss 27,458 11,005 22,271
Change in fair value of warrants (1,524) (3,341) (3,497)
Finance expenses 982 483 2,195
Finance income (424) (868) (992)
Finance income, net (966) (3,726) (2,294)
Loss for the year 26,492 7,279 19,977
Items that will be transferred to profit or loss:      
Loss (profit) from cash flow hedges 19 (25)
Total comprehensive loss for the year 26,492 7,298 19,952
Loss attributable to:      
Owners of the Company 26,386 7,240 19,880
Non-controlling interests 106 39 97
Loss for the year 26,492 7,279 19,977
Total comprehensive loss attributable to:      
Owners of the Company 26,386 7,259 19,855
Non-controlling interests 106 39 97
Total comprehensive loss for the year $ 26,492 $ 7,298 $ 19,952
Loss per share information      
Basic loss per Share – USD (in Dollars per share) $ 0.027 [1] [1]
Diluted loss per Share – USD (in Dollars per share) $ 0.027 [1] [1]
Number of ADSs used in calculation (in Shares) 480,053 [1] [1]
Number of Shares used in calculation (in Shares) 960,106,739 [1] [1]
ADS – USD      
Loss per share information      
Basic loss per Share – USD (in Dollars per share) $ 54.96 [1] [1]
Diluted loss per Share – USD (in Dollars per share) $ 54.96 [1] [1]
[1] Restated to reflect the 1:10 change in the ADS ratio from 1:200 to 1:2,000 ordinary shares per ADS (see Note 9A).